Skip to content

CIK 0001770141

UPH UpHealth, Inc.

Insider trading from SEC Form 4. Last filing Jun 7, 2024.

In brief

UpHealth, Inc. (UPH) has 14 SEC Form 4 filings on file from 9 insiders, the latest filed on Jun 7, 2024. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

1 open-market trade has been scored at UPH. The newest: Avi S Katz (director) sold $112 of stock on Nov 21, 2023, filed Nov 22, 2023, scored 15 (weak).

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company

Signals

Open-market buys and sells at UpHealth, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
15WeakAvi S Katz
director
sell
$112
280 shares
-2%-

Transactions

Every row filed, 18 in all.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Mar 7, 2024Martin S A Beck
Chief Executive Officer
FTax withholding
Common Stock
-932$0.70$65236,160Jun 7, 2024
Apr 11, 2024Martin S A Beck
Chief Executive Officer
MOption exercise
Common Stock
+12,340--48,500Jun 7, 2024
Apr 11, 2024Martin S A Beck
Chief Executive Officer
FTax withholding
Common Stock
-3,658$1.04$3,80444,842Jun 7, 2024
May 22, 2024Martin S A Beck
Chief Executive Officer
FTax withholding
Common Stock
-699$0.48$33644,143Jun 7, 2024
Apr 11, 2024Martin S A Beck
Chief Executive Officer
MOption exercise
Performance Based Restricted Stock Unitderivative
-7,340$0.00$00Jun 7, 2024
Apr 11, 2024Martin S A Beck
Chief Executive Officer
MOption exercise
Performance Based Restricted Stock Unitderivative
-5,000$0.00$04,350Jun 7, 2024
Feb 13, 2024Martin S A Beck
Chief Executive Officer
AGrant or award
Employee stock option (right to buy)derivative
+1,300,000$0.00$01,300,000Feb 15, 2024
Jan 31, 2024James S Greene
director
AGrant or award
Common Stock
+100,000$0.00$0100,000Feb 2, 2024
Jan 31, 2024Mark Guinan
director
AGrant or award
Common Stock
+100,000$0.00$0160,606Feb 2, 2024
Jan 31, 2024Agnes Rey-Giraud
director
AGrant or award
Common Stock
+100,000$0.00$0114,405Feb 2, 2024
Jan 31, 2024Mariya Pylypiv
director
AGrant or award
Common Stock
+100,000$0.00$0795,714Feb 2, 2024
Jan 31, 2024Luis Machuca
director
AGrant or award
Common Stock
+100,000$0.00$0160,606Feb 2, 2024
Jan 31, 2024Avi S Katz
director
AGrant or award
Common Stock
+100,000$0.00$0113,886Feb 2, 2024
Jan 31, 2024Chirinjeev Kathuria
director, owner
AGrant or award
Common Stock
+100,000$0.00$03,955,113Feb 2, 2024
Jan 31, 2024Raluca Dinu
director
AGrant or award
Common Stock
+100,000$0.00$0113,905Feb 2, 2024
Nov 27, 2023Martin S A Beck
Chief Executive Officer
FTax withholding
Common Stock
-701$0.61$42837,092Nov 28, 2023
Nov 21, 2023Avi S Katz
director
SOpen-market sale
Common Stock
-280$0.40$11213,886Nov 22, 2023
Aug 22, 2023Martin S A Beck
Chief Executive Officer
FTax withholding
Common Stock
-701$1.33$93237,793Oct 11, 2023

Insiders

Everyone who has filed a Form 4 here.

Questions about UPH

Answered from the filings on this page, as of the latest one.

Are insiders buying UPH?

No. In the last 90 days no insider at UpHealth, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade UPH on the open market?

Avi S Katz (director) sold $112 of UPH on Nov 21, 2023 and filed the Form 4 on Nov 22, 2023. InsiderTell scored 15 (weak).

How many insiders file Form 4 at UpHealth, Inc.?

9 people have filed a Form 4 at UpHealth, Inc., among them Martin S A Beck (Chief Executive Officer), Raluca Dinu (CEO, director and 10% owner), James S Greene (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

UPH insider trading: UpHealth, Inc. | InsiderTell